Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14

Molecular and Cellular Biology

Volumn 31, Issue 22, 2011, Pages 4609-4622

  Asselin Labat, Marie Liesse ^a,b   Sutherland, Kate D ^a,e   Vaillant, François ^a,b   Gyorki, David E ^a,b   Wu, Di ^a,b   Holroyd, Sheridan ^a   Breslin, Kelsey ^a   Ward, Teresa ^a   Shi, Wei ^a,b   Bath, Mary L ^a   Deb, Siddhartha ^c   Fox, Stephen B ^c   Smyth, Gordon K ^a,b   Lindeman, Geoffrey J ^a,b,d   Visvader, Jane E ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; CASPASE 14; CD14 ANTIGEN; CD24 ANTIGEN; CYTOKERATIN 18; ESTROGEN RECEPTOR ALPHA; GREEN FLUORESCENT PROTEIN; SMOOTH MUSCLE ACTIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR GATA 3; TUMOR SUPPRESSOR PROTEIN; VIRUS MIDDLE T ANTIGEN;

ALLELE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; CASPASE 14 GENE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GATA 3 GENE; GENE LOSS; GENE OVEREXPRESSION; HAPLOINSUFFICIENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MORPHOGENESIS; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE; POLYOMA VIRUS; PRECANCER; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; STEM CELL; TRANSGENE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CASPASE 14; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MIDDLE AGED; STEM CELLS;

EID: 83255186736     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05766-11     Document Type: Article

References (47)

1. Albergaria, A., et al. 2009. Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast Cancer Res. 11:R40.
2. Arnold, J. M., et al. 2010. Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors. Breast Cancer Res. Treat. 119:491-496.
3. Asselin-Labat, M. L., et al. 2007. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9:201-209.
4. Bertucci, F., et al. 2000. Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum. Mol. Genet. 9:2981-2991.
5. Bouras, T., et al. 2008. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 3:429-441.
6. Chien, A. J., R. B. Presland, and M. K. Kuechle. 2002. Processing of native caspase-14 occurs at an atypical cleavage site in normal epidermal differentiation. Biochem. Biophys. Res. Commun. 296:911-917.
7. Denecker, G., et al. 2007. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat. Cell Biol. 9:666-674.
8. Dydensborg, A. B., et al. 2009. GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis. Oncogene 28:2634-2642.
9. Eeckhoute, J., et al. 2007. Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res. 67:6477-6483.
10. Gentleman, R. C., et al. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5:R80.
11. Guy, C. T., R. D. Cardiff, and W. J. Muller. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12:954-961.
12. Herschkowitz, J. I., et al. 2007. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 8:R76.
13. Hoch, R. V., D. A. Thompson, R. J. Baker, and R. J. Weigel. 1999. GATA-3 is expressed in association with estrogen receptor in breast cancer. Int. J. Cancer 84:122-128.
14. Hsu, S., et al. 2007. Expression of caspase-14 reduces tumorigenicity of skin cancer cells. In Vivo 21:279-283.
15. Hu, Y., and G. K. Smyth. 2009. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347:70-78.
16. Jenssen, T. K., W. P. Kuo, T. Stokke, and E. Hovig. 2002. Associations between gene expressions in breast cancer and patient survival. Hum. Genet. 111:411-420.
17. Kendrick, H., et al. 2008. Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMC Genomics 9:591.
18. Koenig, U., W. Sommergruber, and S. Lippens. 2005. Aberrant expression of caspase-14 in epithelial tumors. Biochem. Biophys. Res. Commun. 335:309-313.
19. Kouros-Mehr, H., et al. 2008. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13:141-152.
20. Kouros-Mehr, H., E. M. Slorach, M. D. Sternlicht, and Z. Werb. 2006. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127:1041-1055.
21. Krajewska, M., et al. 2005. Tumor-associated alterations in caspase-14 expression in epithelial malignancies. Clin. Cancer Res. 11:5462-5471.
22. Kurek, D., G. A. Garinis, J. H. van Doorninck, J. van der Wees, and F. G. Grosveld. 2007. Transcriptome and phenotypic analysis reveals Gata3-dependent signalling pathways in murine hair follicles. Development 134:261-272.
23. Lim, E., et al. 2009. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 15:907-913.
24. Lim, E., et al. 2010. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res. 12:R21.
25. Lin, E. Y., et al. 2003. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 163:2113-2126.
26. Mehra, R., et al. 2005. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res. 65:11259-11264.
27. Nguyen, D. X., P. D. Bos, and J. Massague. 2009. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9:274-284.
28. Park, S. Y., et al. 2010. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin. Cancer Res. 16:876-887.
29. Pei, X. H., et al. 2009. CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Cancer Cell 15:389-401.
30. Perou, C. M., et al. 2000. Molecular portraits of human breast tumours. Nature 406:747-752.
31. Ritchie, M. E., et al. 2006. Empirical array quality weights in the analysis of microarray data. BMC Bioinformatics 7:261.
32. Shackleton, M., et al. 2006. Generation of a functional mammary gland from a single stem cell. Nature 439:84-88.
33. Shi, W., A. Oshlack, and G. K. Smyth. 2010. Optimizing the noise versus bias trade-off for Illumina whole genome expression BeadChips. Nucleic Acids Res. 38:e204.
34. Smyth, G. K. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:Article3.
35. Smyth, G. K., J. Michaud, and H. S. Scott. 2005. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21:2067-2075.
36. Sørlie, T., et al. 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 98:10869-10874.
37. Sorlie, T., et al. 2003. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. U. S. A. 100:8418-8423.
38. Sotiriou, C., et al. 2003. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc. Natl. Acad. Sci. U. S. A. 100:10393-10398.
39. Stingl, J. 2009. Detection and analysis of mammary gland stem cells. J. Pathol. 217:229-241.
40. Tan, E. Y., et al. 2007. BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer. Clin. Cancer Res. 13:467-474.
41. Usary, J., et al. 2004. Mutation of GATA3 in human breast tumors. Oncogene 23:7669-7678.
42. Vaillant, F., et al. 2008. The mammary progenitor marker CD61/beta3 in-tegrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res. 68:7711-7717.
43. van Doorninck, J. H., et al. 1999. GATA-3 is involved in the development of serotonergic neurons in the caudal raphe nuclei. J. Neurosci. 19:RC12.
44. Visvader, J. E. 2009. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 23:2563-2577.
45. Voduc, D., M. Cheang, and T. Nielsen. 2008. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value. Cancer Epidemiol. Biomarkers Prev. 17:365-373.
46. West, M., et al. 2001. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci. U. S. A. 98:11462-11467.
47. Yan, P. S., et al. 2000. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer. Clin. Cancer Res. 6:1432-1438.